LEADER 00834nam0-22002771i-450-
001 990002209670403321
005 20111219183339.0
035   $a000220967
035   $aFED01000220967
035   $a(Aleph)000220967FED01
035   $a000220967
100   $a20030910d1986----km-y0itay50------ba
101 0 $aita
102   $aIT
200 1 $aFisiologia della pelle e degli annessi cutanei$fCesare Bruno, Gianni Proserpio
210   $aMilano$cOrganizzazione Editoriale Medico Farmaceutica$d1986
215   $aXIII, 410 p.$d27 cm
700  1$aBruno,$bCesare$0361655
701  1$aProserpio,$bGianni$090379
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002209670403321
952   $a80 XV 33$b254$fFFABC
959   $aFFABC
996   $aFisiologia della pelle e degli annessi cutanei$9395704
997   $aUNINA

LEADER 02443nam  2200589Ia 450 
001 9910782032203321
005 20230721032359.0
010   $a0-309-17979-3
010   $a1-280-84426-4
010   $a9786610844265
010   $a0-309-66330-X
035   $a(CKB)1000000000522906
035   $a(EBL)3378241
035   $a(SSID)ssj0000276695
035   $a(PQKBManifestationID)11237826
035   $a(PQKBTitleCode)TC0000276695
035   $a(PQKBWorkID)10226733
035   $a(PQKB)10810889
035   $a(MiAaPQ)EBC3378241
035   $a(Au-PeEL)EBL3378241
035   $a(CaPaEBR)ebr10176197
035   $a(CaONFJC)MIL84426
035   $a(OCoLC)923278172
035   $a(EXLCZ)991000000000522906
100   $a20070420d2007      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAdverse drug event reporting$b[electronic resource] $ethe roles of consumers and health-care professionals : workshop summary /$fJeffrey M. Drazen ... [et al], rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy ; Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$dc2007
215   $a1 online resource (82 p.)
300   $aSummary of a workshop which took place on November 3 and 4, 2005, in Washington, D.C.
311   $a0-309-10276-6 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""Summary""; ""1 Introduction""; ""2 Current Adverse Event Reporting Systems""; ""3 Active Surveillance Systems""; ""4 Consumer Involvement in Reporting Adverse Events""; ""5 Drug-Drug Interactions""; ""6 Drug Labels""; ""References""; ""Appendixes""; ""A Workshop Agenda""; ""B Speaker Biographies""
606   $aDrugs$xSide effects$vCongresses
606   $aDrug monitoring$vCongresses
615  0$aDrugs$xSide effects
615  0$aDrug monitoring
676   $a362.29
701   $aDrazen$b Jeffrey M.$f1946-$01572833
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910782032203321
996   $aAdverse drug event reporting$93848138
997   $aUNINA